Overview
This Mycophenolate REMS-compliant activity was designed to educate healthcare providers about the management of female patients of reproductive potential who are prescribed mycophenolate — particularly those professionals who care/may care for active military members and Veterans. Female members of the Military Community are at a high risk for autoimmune disease and are likely to be prescribed mycophenolate during their child-bearing years. Studies have shown that women in the Military Community often do not receive risk-lowering care when prescribed teratogenic medications like mycophenolate. This microlearning activity provides comprehensive education on reducing the risk of embryofetal toxicity associated with the use of mycophenolate during pregnancy in eight 15-minute episodes. Each episode will be presented as a video, audio-only file, or monograph to allow the learner to create an optional learning experience that best aligns with their learning style.

Target Audience
The intended audience includes physicians, nurse practitioners, nurses, physician assistants, pharmacists and other providers involved in the management of female patients of reproductive potential who are prescribed mycophenolate.

Commercial Support
This activity is supported by an independent educational grant from the Mycophenolate REMS Group. This activity is intended to be fully compliant with the Mycophenolate REMS education requirements issued by the U.S. Food and Drug Administration (FDA).

This activity is available as a video, audio-only file, or monograph, allowing learners to choose the format that best aligns with their learning style.

Please select one of the formats below to begin.